MiR-223-3p and miR-22-3p inhibit monosodium urate-induced gouty inflammation by targeting NLRP3.
Xiang WangJingwei ChiBingzi DongLili XuYue ZhouYajing HuangShengnan SunFanxiang WeiYuzhao LiuChuanfeng LiuKui CheWenshan LvYing ChenYangang WangPublished in: International journal of rheumatic diseases (2021)
The findings of the present study show that miR-223-3p and miR-22-3p can reduce the inflammatory effects of gout by inhibiting the expression of NLRP3.